Singapore
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 132.53 M
|
Dec. 31, 2023 | USD 11.57 | -4.06% |
|
Singapore |
|
2 |
USD 8.27 M
|
Dec. 31, 2023 | USD 2.64 | 1.93% |
|
Singapore |
|
3 |
USD 2.35 M
|
Dec. 31, 2023 | USD 3.55 | -1.66% |
|
Singapore |
|
4 |
USD -1.06 M
|
June 30, 2024 | USD 10.41 | 0.13% |
|
Singapore |
The Healthcare company in Singapore with the highest Net Cash Used Provided By Financing Activities is Wave Life Sciences Ltd. (NasdaqGM: WVE) at USD 132.53 M.
The Healthcare company in Singapore with the lowest Net Cash Used Provided By Financing Activities is Prestige BioPharma Limited (KSE: 950210.KS) at USD -1.06 M.
The top 10 Healthcare companies in Singapore by Net Cash Used Provided By Financing Activities are Wave Life Sciences Ltd., CytoMed Therapeutics Limited, EUDA Health Holdings Limited and Prestige BioPharma Limited.
The bottom 10 Healthcare companies in Singapore by Net Cash Used Provided By Financing Activities are Prestige BioPharma Limited, EUDA Health Holdings Limited, CytoMed Therapeutics Limited and Wave Life Sciences Ltd..